Editorial: Papillary thyroid microcarcinoma outcomes and implications for treatment

被引：66

作者：

Pearce, EN ^{[1
]}

Braverman, LE ^{[1
]}

机构：

[1] Boston Univ, Sch Med, Boston Med Ctr, Sect Endocrinol Diabet & Nutr, Boston, MA 02118 USA

来源：

关键词：

D O I：

10.1210/jc.2004-1189

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3710 / 3712

页数：3

共 34 条

[1] Appetecchia M, 2002, J EXP CLIN CANC RES, V21, P159
[2] Bakiri F, 1998, CANCER, V82, P1146, DOI 10.1002/(SICI)1097-0142(19980315)82:6&lt
[3] 1146::AID-CNCR20&gt
[4] 3.0.CO
[5] 2-5
[6] Baudin E, 1998, CANCER, V83, P553, DOI 10.1002/(SICI)1097-0142(19980801)83:3<553::AID-CNCR25>3.0.CO
[7] 2-U
[8] Assessment of the morbidity and complications of total thyroidectomy
Bhattacharyya, N
Fried, MP
[J]. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2002, 128 (04) : 389 - 392
[9] Changes in clinical presentation, management and outcome in 1348 patients with differentiated thyroid carcinoma: Experience in a single institute in Hong Kong, 1960-2000
Chow, SM
Law, SCK
Au, SK
Mang, O
Yau, S
Yuen, KT
Lau, WH
[J]. CLINICAL ONCOLOGY, 2003, 15 (06) : 329 - 336
[10] Papillary microcarcinoma of the thyroid - Prognostic significance of lymph node metastasis and multifocality
Chow, SM
Law, SCK
Chan, JKC
Au, SK
Yau, S
Lau, WH
[J]. CANCER, 2003, 98 (01) : 31 - 40